Connect Sign In
ARUP Consult, a free source of expert guidance in laboratory testing, has released new resources on testing for polycystic ovary syndrome and autoimmune encephalitis.
ARUP Consult, a free source of expert guidance in laboratory testing, has released updated resources on testing for osteoporosis, paraneoplastic pemphigus, and epilepsy.
ARUP Consult, a free source of expert guidance in laboratory testing, has released updated resources on testing for Lyme disease, diagnosing pneumonia, and evaluating infertility.
ARUP Consult, a free source of expert guidance in laboratory testing, has updated resources on testing for human papillomavirus, chronic lymphocytic leukemia, and amenorrhea.
ARUP Laboratories has received FDA approval for its companion diagnostic immunoassay, AAV5 DetectCDx™, which helps determine patient eligibility for a new gene therapy for severe hemophilia A.
ARUP’s Clinical Trials and PharmaDx groups supported Blueprint Medicines’ clinical trials that led to FDA approval for AYVAKIT® (avapritinib), a new treatment for indolent systemic mastocytosis.
ARUP Consult, a free source of expert guidance in laboratory testing, has updated resources on autoimmune neurologic diseases, drug detection in newborns, and common variable immunodeficiency.
ARUP Section Chief Joely Straseski, PhD, will address lab testing for transgender individuals at the 2023 National Transgender Health Summit and the Mountain West Transforming Care Conference.
ARUP Consult, a free source of expert guidance in laboratory testing, has released updated resources on hypopituitarism, diabetes mellitus, and endocrine testing in transgender adults.
ARUP’s new test to detect Candida auris will offer a robust screening tool to help clinical facilities identify patients colonized with the yeast and guide infection prevention measures.
